Mauro David J

CIK 00016211724 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001621172

Recent Transactions

50 trades

Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-11-15$6.17/sh−4,187→ 225,429 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-15$6.69/sh−14,146→ 229,616 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-05-15$10.01/sh−867→ 243,762 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-09$10.09/sh−1,892→ 244,629 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (RIght to Buy)
2024-02-09+99,537→ 99,537 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-09+49,768→ 246,521 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-09+6,040→ 196,753 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-06-01+381,426→ 381,426 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-06-01+190,713→ 190,713 total
Award
Codiak BioSciences, Inc.
Stock Option (Right to Buy)
2023-01-24+190,000→ 190,000 total
Award
Codiak BioSciences, Inc.
Restricted Stock Units
2022-09-16+80,000→ 80,000 total
Award
Codiak BioSciences, Inc.
Stock Option (Right to Buy)
2022-05-02+200,000→ 200,000 total
Award
Codiak BioSciences, Inc.
Restricted Stock Units
2022-05-02+20,000→ 20,000 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-10-05$31.30/sh−7,803→ 1,289 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-10-05$30.26/sh−5,908→ 9,092 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-10-05$1.89/sh+15,000→ 15,000 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-10-05$32.06/sh−1,289→ 0 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-10-05−15,000→ 137,610 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-09-07$1.89/sh+15,000→ 15,000 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-09-07$35.91/sh−7,487→ 7,513 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-09-07−15,000→ 167,610 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-09-07$37.79/sh−4,640→ 0 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-09-07$36.92/sh−2,873→ 4,640 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-05$1.89/sh+15,000→ 15,000 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-08-05−15,000→ 167,610 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-05$32.15/sh−6,721→ 100 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-05$31.03/sh−2,063→ 6,821 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-05$29.93/sh−6,116→ 8,884 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-08-05$32.63/sh−100→ 0 total
Award
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-07-20+95,000→ 95,000 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (Right to Buy)
2021-07-06−15,000→ 182,610 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-07-06$28.84/sh−300→ 0 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-07-06$27.17/sh−10,445→ 4,555 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-07-06$28.13/sh−4,255→ 300 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-07-06$1.89/sh+15,000→ 15,000 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-06-07$32.73/sh−12,700→ 0 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-06-07$30.35/sh−1,400→ 13,600 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-06-07−15,000→ 197,610 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-06-07$1.89/sh+15,000→ 15,000 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-06-07$31.62/sh−900→ 12,700 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-05-05$40.30/sh−10,476→ 1,109 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-05-05$39.36/sh−3,415→ 11,585 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-05-05$1.89/sh+15,000→ 15,000 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-05-05−15,000→ 212,610 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-05-05$41.07/sh−1,109→ 0 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-27$1.89/sh+25,000→ 25,000 total
Exercise/Conversion
Prelude Therapeutics Inc$PRLD
Employee Stock Option (right to buy)
2021-04-27−25,000→ 227,610 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-27$35.68/sh−15,601→ 1,711 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-27$36.11/sh−1,711→ 0 total
Sale
Prelude Therapeutics Inc$PRLD
Common Stock
2021-04-27$34.66/sh−7,688→ 17,312 total

Companies

Recent Filings

Address

305 COLLEGE ROAD EAST

PRINCETON, NJ, 08540

View on SEC.gov